Who owns ACUMEN PHARMACEUTICALS INC?
- Ticker: ABOS
- CUSIP Number: 00509g209
Tip: Access positions for across all investors
Analyze quarterly positions in Acumen Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acumen Pharmaceuticals stock
Who bought or sold ACUMEN PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 15M | $57M | 0% | Dec 2023 |
|
| Franklin Resources | 3.4M | $13M | 18% | Dec 2023 |
|
| Laurion Capital Management | 1.9M | $7.3M | 0% | Dec 2023 |
|
| Vanguard Group | 1.8M | $7.1M | -1% | Dec 2023 |
|
| Millennium Management | 1.5M | $5.7M | -16% | Dec 2023 |
|
| Alyeska Investment Group | 733k | $2.8M | 19% | Dec 2023 |
|
| Jane Street | 605k | $2.3M | 3502% | Dec 2023 |
|
| Hudson Bay Capital Management | 564k | $2.2M | 8% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 562k | $2.2M | -13% | Dec 2023 |
|
| Pathstone Holdings | 479k | $1.8M | 100% | Dec 2023 |
|
| Ikarian Capital | 315k | $1.2M | 0% | Dec 2023 |
|
| Tang Capital Management | 247k | $948k | 100% | Dec 2023 |
|
| Two Sigma Investments | 244k | $939k | 85% | Dec 2023 |
|
| Citigroup | 148k | $568k | 284% | Dec 2023 |
|
| Man Group | 145k | $555k | 100% | Dec 2023 |
|
| Citadel Advisors | 144k | $555k | 263% | Dec 2023 |
|
| D. E. Shaw & Co | 138k | $530k | 100% | Dec 2023 |
|
| Two Sigma Advisers | 130k | $498k | 546% | Dec 2023 |
|
| Caption Management | 120k | $461k | 0% | Dec 2023 |
|
| Goldman Sachs Group | 115k | $441k | 100% | Dec 2023 |
|
| Bank of America Corporation | 104k | $401k | 533% | Dec 2023 |
|
| Jump Financial | 103k | $396k | 204% | Dec 2023 |
|
| Catalyst Financial Partners | 90k | $311k | 0% | Mar 2024 |
|
| 683 Capital Management | 78k | $301k | 100% | Dec 2023 |
|
| Dimensional Fund Advisors | 56k | $214k | -26% | Dec 2023 |
|
| Squarepoint Ops | 53k | $203k | 100% | Dec 2023 |
|
| Barclays | 47k | $183k | 111% | Dec 2023 |
|
| Jpmorgan Chase & Co | 34k | $130k | 208% | Dec 2023 |
|
| Cubist Systematic Strategies | 34k | $130k | 100% | Dec 2023 |
|
| Virtu Financial | 24k | $91k | 100% | Dec 2023 |
|
| Balyasny Asset Management | 21k | $79k | 100% | Dec 2023 |
|
| Gail Mannix | 18k | $73k | 100% | Mar 2024 |
|
| Occudo Quantitative Strategies | 17k | $65k | 100% | Dec 2023 |
|
| Stifel Financial | 16k | $62k | 100% | Dec 2023 |
|
| Chicago Partners Investment | 14k | $44k | -24% | Mar 2024 |
|
| Wells Fargo & Company | 2.2k | $8.5k | 1037% | Dec 2023 |
|
| Point72 Asia | 2.0k | $7.7k | 100% | Dec 2023 |
|
| Advisory Services Network | 1.0k | $3.8k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 668.00 | $2.4k | 555% | Dec 2023 |
|
| Advisor Group Holdings | 400.00 | $1.5k | 100% | Dec 2023 |
|
| UBS Group | 8.00 | $31.000000 | -92% | Dec 2023 |
|
Who sold out of Acumen Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Boxer Capital | Sep 2023 | 2.2M | $9.2M |
| Dr. Jeffrey R. Jay, M.D. | Sep 2023 | 1.1M | $4.5M |
| Wellington Management Company | Sep 2023 | 104k | $433k |
| Marshall Wace | Sep 2023 | 26k | $106k |
| Simplex Trading | Dec 2023 | 21k | $82k |
| Pinnacle Wealth Management Advisory | Sep 2023 | 18k | $75k |
| Global Retirement Partners | Dec 2023 | 2.0k | $7.3k |
| China Universal Asset Management | Sep 2023 | 1.5k | $6.0k |
| Cutler | Dec 2023 | 1.2k | $4.0k |
| Zurcher Kantonalbank | Dec 2023 | 413.00 | $1.6k |
| Daiwa Securities Group | Sep 2023 | 165.00 | $999.999000 |